BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 19960054)

  • 1. CREB: A Key Regulator of Normal and Neoplastic Hematopoiesis.
    Sandoval S; Pigazzi M; Sakamoto KM
    Adv Hematol; 2009; 2009():634292. PubMed ID: 19960054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sox4 cooperates with CREB in myeloid transformation.
    Sandoval S; Kraus C; Cho EC; Cho M; Bies J; Manara E; Accordi B; Landaw EM; Wolff L; Pigazzi M; Sakamoto KM
    Blood; 2012 Jul; 120(1):155-65. PubMed ID: 22627767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-34b promoter hypermethylation induces CREB overexpression and contributes to myeloid transformation.
    Pigazzi M; Manara E; Bresolin S; Tregnago C; Beghin A; Baron E; Giarin E; Cho EC; Masetti R; Rao DS; Sakamoto KM; Basso G
    Haematologica; 2013 Apr; 98(4):602-10. PubMed ID: 23100280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of cyclic AMP response element binding protein in human leukemias.
    Shankar DB; Cheng JC; Sakamoto KM
    Cancer; 2005 Nov; 104(9):1819-24. PubMed ID: 16196046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of CREB as a proto-oncogene in hematopoiesis.
    Kinjo K; Sandoval S; Sakamoto KM; Shankar DB
    Cell Cycle; 2005 Sep; 4(9):1134-5. PubMed ID: 16096372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CREB is a critical regulator of normal hematopoiesis and leukemogenesis.
    Cheng JC; Kinjo K; Judelson DR; Chang J; Wu WS; Schmid I; Shankar DB; Kasahara N; Stripecke R; Bhatia R; Landaw EM; Sakamoto KM
    Blood; 2008 Feb; 111(3):1182-92. PubMed ID: 17975014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CREB and leukemogenesis.
    Cho EC; Mitton B; Sakamoto KM
    Crit Rev Oncog; 2011; 16(1-2):37-46. PubMed ID: 22150306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia.
    Shankar DB; Cheng JC; Kinjo K; Federman N; Moore TB; Gill A; Rao NP; Landaw EM; Sakamoto KM
    Cancer Cell; 2005 Apr; 7(4):351-62. PubMed ID: 15837624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-34b targets cyclic AMP-responsive element binding protein in acute myeloid leukemia.
    Pigazzi M; Manara E; Baron E; Basso G
    Cancer Res; 2009 Mar; 69(6):2471-8. PubMed ID: 19258499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ICER expression inhibits leukemia phenotype and controls tumor progression.
    Pigazzi M; Manara E; Baron E; Basso G
    Leukemia; 2008 Dec; 22(12):2217-25. PubMed ID: 18784739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential role of CREB as a prognostic marker in acute myeloid leukemia.
    Cheng JC; Esparza S; Sandoval S; Shankar D; Fu C; Sakamoto KM
    Future Oncol; 2007 Aug; 3(4):475-80. PubMed ID: 17661722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CREB engages C/EBPδ to initiate leukemogenesis.
    Tregnago C; Manara E; Zampini M; Bisio V; Borga C; Bresolin S; Aveic S; Germano G; Basso G; Pigazzi M
    Leukemia; 2016 Sep; 30(9):1887-96. PubMed ID: 27118402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small molecule inhibition of cAMP response element binding protein in human acute myeloid leukemia cells.
    Mitton B; Chae HD; Hsu K; Dutta R; Aldana-Masangkay G; Ferrari R; Davis K; Tiu BC; Kaul A; Lacayo N; Dahl G; Xie F; Li BX; Breese MR; Landaw EM; Nolan G; Pellegrini M; Romanov S; Xiao X; Sakamoto KM
    Leukemia; 2016 Dec; 30(12):2302-2311. PubMed ID: 27211267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Niclosamide suppresses acute myeloid leukemia cell proliferation through inhibition of CREB-dependent signaling pathways.
    Chae HD; Cox N; Dahl GV; Lacayo NJ; Davis KL; Capolicchio S; Smith M; Sakamoto KM
    Oncotarget; 2018 Jan; 9(4):4301-4317. PubMed ID: 29435104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of the bone marrow niche in hematopoiesis, leukemogenesis, and chemotherapy resistance in acute myeloid leukemia.
    Wang A; Zhong H
    Hematology; 2018 Dec; 23(10):729-739. PubMed ID: 29902132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-34b Targets HSF1 to Suppress Cell Survival in Acute Myeloid Leukemia.
    Li G; Song Y; Zhang Y; Wang H; Xie J
    Oncol Res; 2016; 24(2):109-16. PubMed ID: 27296951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression profile of CREB knockdown in myeloid leukemia cells.
    Pellegrini M; Cheng JC; Voutila J; Judelson D; Taylor J; Nelson SF; Sakamoto KM
    BMC Cancer; 2008 Sep; 8():264. PubMed ID: 18801183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of expression of the ubiquitous transcription factor cAMP response element-binding protein (CREB) and compensatory overexpression of the activator CREMtau in the human adrenocortical cancer cell line H295R.
    Groussin L; Massias JF; Bertagna X; Bertherat J
    J Clin Endocrinol Metab; 2000 Jan; 85(1):345-54. PubMed ID: 10634409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Requirement for cAMP-response element (CRE) binding protein/CRE modulator transcription factors in thyrotropin-induced proliferation of dog thyroid cells in primary culture.
    Uyttersprot N; Costagliola S; Dumont JE; Miot F
    Eur J Biochem; 1999 Jan; 259(1-2):370-8. PubMed ID: 9914516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.